Cargando…
Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center
Macroprolactinemia frequently causes misdiagnosis, unnecessary investigation and inappropriate treatment in hyperprolactinemic patients. Aim of this study is to investigate the prevalence and clinical characteristics of Thai patients with macroprolactinemia. We performed a cross-sectional study in 5...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282613/ https://www.ncbi.nlm.nih.gov/pubmed/32550971 http://dx.doi.org/10.11604/pamj.2020.36.8.22923 |
_version_ | 1783544150783688704 |
---|---|
author | Chutpiboonwat, Phronpan Yenpinyosuk, Kanchana Sridama, Vitaya Kunjan, Supaksorn Klaimukh, Karuna Snabboon, Thiti |
author_facet | Chutpiboonwat, Phronpan Yenpinyosuk, Kanchana Sridama, Vitaya Kunjan, Supaksorn Klaimukh, Karuna Snabboon, Thiti |
author_sort | Chutpiboonwat, Phronpan |
collection | PubMed |
description | Macroprolactinemia frequently causes misdiagnosis, unnecessary investigation and inappropriate treatment in hyperprolactinemic patients. Aim of this study is to investigate the prevalence and clinical characteristics of Thai patients with macroprolactinemia. We performed a cross-sectional study in 56 hyperprolactinemic patients (51 women and 5 men) whose sera were subsequently tested for the presence of macroprolactin. Recovery of less than 40% of serum prolactin after polyethylene glycol (PEG) precipitation was indicative of macroprolactinemia. Our study revealed 19.64% (11/56) of patients with hyperprolactinemia were found to have a preponderance of macroprolactin. All patients with macroprolactinemia were women, of which eight of them were initially diagnosed as idiopathic hyperprolactinemia and mistreated with dopamine agonist medications. Interestingly, neuroradiological abnormalities were reported in three patients with macroprolactinemia, 2 cases with prolactinoma and one case with stalk effect hyperprolactinemia. In conclusion, nearly one-fifth of our patients with hyperprolactinemia have macroprolactinemia. This finding suggests that the diagnostic algorithm of all patients with hyperprolactinemia should include the PEG precipitation test as the initial step. Domain: Endocrinology |
format | Online Article Text |
id | pubmed-7282613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The African Field Epidemiology Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-72826132020-06-17 Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center Chutpiboonwat, Phronpan Yenpinyosuk, Kanchana Sridama, Vitaya Kunjan, Supaksorn Klaimukh, Karuna Snabboon, Thiti Pan Afr Med J Case Series Macroprolactinemia frequently causes misdiagnosis, unnecessary investigation and inappropriate treatment in hyperprolactinemic patients. Aim of this study is to investigate the prevalence and clinical characteristics of Thai patients with macroprolactinemia. We performed a cross-sectional study in 56 hyperprolactinemic patients (51 women and 5 men) whose sera were subsequently tested for the presence of macroprolactin. Recovery of less than 40% of serum prolactin after polyethylene glycol (PEG) precipitation was indicative of macroprolactinemia. Our study revealed 19.64% (11/56) of patients with hyperprolactinemia were found to have a preponderance of macroprolactin. All patients with macroprolactinemia were women, of which eight of them were initially diagnosed as idiopathic hyperprolactinemia and mistreated with dopamine agonist medications. Interestingly, neuroradiological abnormalities were reported in three patients with macroprolactinemia, 2 cases with prolactinoma and one case with stalk effect hyperprolactinemia. In conclusion, nearly one-fifth of our patients with hyperprolactinemia have macroprolactinemia. This finding suggests that the diagnostic algorithm of all patients with hyperprolactinemia should include the PEG precipitation test as the initial step. Domain: Endocrinology The African Field Epidemiology Network 2020-05-06 /pmc/articles/PMC7282613/ /pubmed/32550971 http://dx.doi.org/10.11604/pamj.2020.36.8.22923 Text en © Phronpan Chutpiboonwat et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Series Chutpiboonwat, Phronpan Yenpinyosuk, Kanchana Sridama, Vitaya Kunjan, Supaksorn Klaimukh, Karuna Snabboon, Thiti Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center |
title | Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center |
title_full | Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center |
title_fullStr | Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center |
title_full_unstemmed | Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center |
title_short | Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center |
title_sort | macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282613/ https://www.ncbi.nlm.nih.gov/pubmed/32550971 http://dx.doi.org/10.11604/pamj.2020.36.8.22923 |
work_keys_str_mv | AT chutpiboonwatphronpan macroprolactinemiainpatientswithhyperprolactinemiaanexperiencefromasingletertiarycenter AT yenpinyosukkanchana macroprolactinemiainpatientswithhyperprolactinemiaanexperiencefromasingletertiarycenter AT sridamavitaya macroprolactinemiainpatientswithhyperprolactinemiaanexperiencefromasingletertiarycenter AT kunjansupaksorn macroprolactinemiainpatientswithhyperprolactinemiaanexperiencefromasingletertiarycenter AT klaimukhkaruna macroprolactinemiainpatientswithhyperprolactinemiaanexperiencefromasingletertiarycenter AT snabboonthiti macroprolactinemiainpatientswithhyperprolactinemiaanexperiencefromasingletertiarycenter |